Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wolff

Showing results (721-730 of 831) with videos related to

Pageof 84
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2000
The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetineK Rasmussen, D O Calligaro, J F Czachura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2024
Academic Uphill Battle to Personalize Treatment for Patients With Stage II/III Triple-Negative Breast CancerMarleen Kok, Robbert-Jan Gielen, Sylvia Adams, et al.
JCO Precision Oncology|July 14, 2018
Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor BoardW Brian Dalton, Patrick M Forde, Hyunseok Kang, et al.
Breast Cancer Research and Treatment|April 21, 2019
Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial)Jennifer R Bellon, Hao Guo, William T Barry, et al.
The Journal of Infectious Diseases|February 18, 1998
Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection GroupB S Graham, M J McElrath, R I Connor, et al.
Breast Cancer Research and Treatment|May 19, 2015
Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial)Kathryn J Ruddy, Hao Guo, William Barry, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 31, 2023
Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)Maeve A Hennessy, Jeffrey P Leal, Chiung-Yu Huang, et al.
Cancer Research Communications|September 1, 2022
Development of an automated liquid biopsy assay for methylated markers in advanced breast cancerMary Jo Fackler, Suzana Tulac, Neesha Venkatesan, et al.
JCO Oncology Practice|July 1, 2020
Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific ApproachJennifer Y Sheng, Cesar A Santa-Maria, Neha Mangini, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2025
Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerizationVincent H J Leonard, Dianna B Vidales, Benjamin R Taft, et al.
Pageof 84

Showing results (721-730 of 831) with videos related to

Sort By:
Pageof 84
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2000
The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetineK Rasmussen, D O Calligaro, J F Czachura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2024
Academic Uphill Battle to Personalize Treatment for Patients With Stage II/III Triple-Negative Breast CancerMarleen Kok, Robbert-Jan Gielen, Sylvia Adams, et al.
JCO Precision Oncology|July 14, 2018
Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor BoardW Brian Dalton, Patrick M Forde, Hyunseok Kang, et al.
Breast Cancer Research and Treatment|April 21, 2019
Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial)Jennifer R Bellon, Hao Guo, William T Barry, et al.
The Journal of Infectious Diseases|February 18, 1998
Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection GroupB S Graham, M J McElrath, R I Connor, et al.
Breast Cancer Research and Treatment|May 19, 2015
Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial)Kathryn J Ruddy, Hao Guo, William Barry, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 31, 2023
Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)Maeve A Hennessy, Jeffrey P Leal, Chiung-Yu Huang, et al.
Cancer Research Communications|September 1, 2022
Development of an automated liquid biopsy assay for methylated markers in advanced breast cancerMary Jo Fackler, Suzana Tulac, Neesha Venkatesan, et al.
JCO Oncology Practice|July 1, 2020
Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific ApproachJennifer Y Sheng, Cesar A Santa-Maria, Neha Mangini, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2025
Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerizationVincent H J Leonard, Dianna B Vidales, Benjamin R Taft, et al.
Pageof 84